---  
layout: startup_page  
title: "Normunity"  
id: "normunity.com"  
permalink: "/normunitynormunity.com01132025/"  
website: "https://normunity.com/"  
funding_round: "Series B"  
funding_amount: "$75M"  
investors: "Samsara Biocapital, Enavate Sciences, Pfizer Ventures, Regeneron Ventures, YK Bioventures, Canaan Partners, Sanofi Ventures, Taiho Ventures, Osage Venture Partners, HongShan Capital Group, Connecticut Innovations"  
about: "Normunity is a biotechnology company developing novel anti-cancer therapies targeting untapped biological mechanisms at the interface of the immune system and tumors. Their lead program, NRM-823, is a T cell engager aiming to treat multiple solid tumors and is expected to enter clinical trials in 2025. The company utilizes a proprietary target discovery process to build its pipeline of anti-cancer medicines."  
markets: "Biotechnology, Oncology, Immunotherapy, Medical, Therapeutics"  
hq: "New Haven, Connecticut, United States"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/normunity/"  
twitter: "https://twitter.com/normunity"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/normunity"  
pitchbook: "https://pitchbook.com/profiles/company/495053-83"  

date_display: "13-Jan-2025"  
date: "2025-01-13"

# SEO Optimization  
meta_title: "Normunity - Series B Funding ($75M)"  
meta_description: "Normunity, Normunity is a biotechnology company developing novel anti-cancer therapies targeting untapped biological mechanisms at the interface of the immune sy..."  
meta_keywords: "Normunity, Biotechnology, Oncology, Immunotherapy, Medical, Therapeutics, Series B funding"  
canonical_url: "https://startup.projectstartups.com/normunitynormunity.com01132025/"  
---